Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Use of Lenalidomide in DEL(5q) MDS. a National AIFA (Agenzia Italiana del Farmaco) Registry Study

Francesco Arcioni, MD, Andrea Roncadori, Valeria Di Battista, MD, Giuliana Alimena, MD, Fabrizio Pane, MD, Giuseppe Rossi, Francesco Buccisano, MD, Anna D'Emilio, MD, Nicola Di Renzo, Pietro Leoni, Prof., Giovanni Caocci, Alessandro Rambaldi, MD, Paolo Avanzini, Giuseppe Visani, MD, Sante Tura, MD, Anna Covezzoli, Cristina Mecucci, MD PhD

Blood (2015) 126 (23): 1693.

https://doi.org/10.1182/blood.V126.23.1693.1693

Published: 2015

Journal Articles

Lenalidomide in Myelodysplastic Syndromes with 5q Deletion. Results From the Italian National Cancer Registry

Cristina Mecucci, Andrea Roncadori, Roberta La Starza, Francesco Arcioni, Alessandro Levis, Valeria Santini, Giuliana Alimena, Fabrizio Pane, Giuseppe Rossi, Maria Cantonetti, Anna D'Emilio, Nicola Di Renzo, Pietro Leoni, Giovanni Caocci, Alessandro Rambaldi, MD, Paolo Avanzini, Giuseppe Visani, Sante Tura, Anna Covezzoli

Blood (2012) 120 (21): 3850.

https://doi.org/10.1182/blood.V120.21.3850.3850

Published: 2012

Journal Articles

Lenalidomide Is Effective in Heavily Pretreated Non Hodgkin Lymphoma (NHL): Analysis of a Retrospective Data Collection

Luigi Rigacci, MD, Umberto Vitolo, M. Christina Cox, MD, Liliana Devizzi, MD, Alberto Fabbri, MD, Alfonso Zaccaria, MD, Francesco Zaja, MD, Paolo Paesano, MD, Giuseppe Rossi, MD, Sergio Storti, Sante Tura, MD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 3694.

https://doi.org/10.1182/blood.V120.21.3694.3694

Published: 2012

Journal Articles

Deferasirox Chelation Therapy in Transfusion Dependent MDS Patients. Final Report From the Gimema MDS0306 Prospective Trial

Emanuele Angelucci, MD, Valeria Santini, MD, Anna Angela Di Tucci, MD, Carlo Finelli, MD, Nicola Cantore, MD, Giovanni Quarta, MD, Alfonso Maria D'Arco, MD, Nicola Cascavilla, Giuseppe Saglio, MD, Alessandro Levis, MD, Martina Pettinau, MD, Giovanni Caocci, MD, Enrica Morra, MD, Daniele Vallisa, MD, Giancarlo Latte, MD, Alfonso Piciocchi, Katia Bontempi, Marco Vignetti, MD, Sante Tura, MD

Blood (2012) 120 (21): 425.

https://doi.org/10.1182/blood.V120.21.425.425

Published: 2012

Journal Articles

Lenalidomide Administration in Heavily Pretreated Patients with Non Hodgkin Lymphoma – First Report of the REVEAL Study (REVlimid® Effectiveness of Administration in patients with Lymphoma)

Luigi Rigacci, Francesco Zaja, Alberto Fabbri, Alice Di Rocco, MD, Angelo Michele Carella, MD, Liliana Devizzi, MD, Umberto Vitolo, MD, Pier Luigi Zinzani, MD, PhD, Sante Tura, MD

Blood (2011) 118 (21): 4979.

https://doi.org/10.1182/blood.V118.21.4979.4979

Published: 2011

Journal Articles

Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial

Blood (2010) 116 (21): 2928.

https://doi.org/10.1182/blood.V116.21.2928.2928

Published: 2010

Journal Articles

Quality of Life in Elderly Patients with Essential Thrombocythemia.

Esther Natalie Oliva, MD, Luigi Gugliotta, MD, Maria Cantonetti, MD, Andrea Piccin, MD, PhD, Maria Gabriella Mazzucconi, MD, Anna Candoni, MD, Rossella R Cacciola, Assistant, Professor, Emma Cacciola, MD, Monia Lunghi, MD, Sante Tura, MD

Blood (2009) 114 (22): 4973.

https://doi.org/10.1182/blood.V114.22.4973.4973

Published: 2009

Journal Articles

Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.

Michele Cavo, MD, Giulia Perrone, M.D., Michela Ceccolini, M.D., Vito Michele Lauta, M.D., Massimo Offidani, M.D., Filippo Ballerini, M.D., Lucia Pantani, M.D., Annamaria Brioli, M.D., Silvana Pasini, M.D., Fausto Dore, M.D., Domenico Vertone, M.D., Paola Tacchetti, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Sante Tura, M.D., Michele Baccarani, M.D.

Blood (2007) 110 (11): 730.

https://doi.org/10.1182/blood.V110.11.730.730

Published: 2007

Journal Articles

Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone

Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Francesco Di Raimondo, Lucio Catalano, Alfonso D'Arco, Sonia Ronconi, Claudia Cellini, Massimo Offidani, Giulia Perrone, Michela Ceccolini, Annamaria Brioli, Sante Tura, Michele Baccarani, Michele Cavo

Blood (2006) 108 (12): 3951–3952.

https://doi.org/10.1182/blood-2006-07-033571

Published: 2006

Journal Articles

Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.

Patrizia Tosi, MD, Elena Zamagni, MD, Delia Cangini, MD, Paola Tacchetti, MD, Massimo Offidani, MD, Sonia Ronconi, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Michele Baccarani, MD, Sante Tura, MD, Michele Cavo, MD

Blood (2005) 106 (11): 3461.

https://doi.org/10.1182/blood.V106.11.3461.3461

Published: 2005

Journal Articles

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Pier-Paolo Piccaluga, MD, PhD, Claudio Agostinelli, MD, Simona Zupo, MD, Andrea Califano, PhD, Philip Went, MD, Stefano Ascani, MD, Katia Basso, PhD, Fabio Facchetti, MD, Brunangelo Falini, MD, Manlio Ferrarini, MD, Andrea Gallamini, MD, Ulf Klein, PhD, Domenico Novero, MD, Marco Paulli, MD, Sante Tura, MD, Pier Luigi Zinzani, MD, Michele Baccarani, MD, Riccardo Dalla-Favera, MD, Stefano A. Pileri, MD

Blood (2005) 106 (11): 1217.

https://doi.org/10.1182/blood.V106.11.1217.1217

Published: 2005

Journal Articles

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

Michele Cavo, Elena Zamagni, Patrizia Tosi, Paola Tacchetti, Claudia Cellini, Delia Cangini, Antonio de Vivo, Nicoletta Testoni, Chiara Nicci, Carolina Terragna, Tiziana Grafone, Giulia Perrone, Michela Ceccolini, Sante Tura, Michele Baccarani, for the writing committee of the Bologna 2002 study

Blood (2005) 106 (1): 35–39.

https://doi.org/10.1182/blood-2005-02-0522

Published: 2005

Journal Articles

Thalidomide-Induced Peropheral Neuropathy in Newly Diagnosed and Pre-Treated Multiple Myeloma Patients.

Patrizia Tosi, MD, Elena Zamagni, MD, Claudia Cellini, MD, Delia Cangini, MD, Paola Tacchetti, MD, Giulia Perrone, MD, Sante Tura, MD, Michele Baccarani, MD, Michele Cavo, MD

Blood (2004) 104 (11): 4898.

https://doi.org/10.1182/blood.V104.11.4898.4898

Published: 2004

Journal Articles

Imatinib Therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem Cell Transplantation: A Molecular Analysis.

Blood (2004) 104 (11): 4655.

https://doi.org/10.1182/blood.V104.11.4655.4655

Published: 2004

Journal Articles

Superiority of Double over Single Autologous Stem Cell Transplantation as First-Line Therapy for Multiple Myeloma.

Michele Cavo, Claudia Cellini, Elena Zamagni, Patrizia Tosi, Delia Cangini, Paola Tacchetti, Antonio De Vivo, Giulia Perrone, Roberto Massimo Lemoli, Sante Tura, Michele Baccarani

Blood (2004) 104 (11): 536.

https://doi.org/10.1182/blood.V104.11.536.536

Published: 2004

Journal Articles

Superiority of First-Line Thalidomide-Dexamethasone over Vincristine-Doxorubicin-Dexamethasone in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.

Michele Cavo, Paola Tacchetti, Elena Zamagni, Patrizia Tosi, Delia Cangini, Claudia Cellini, Nicoletta Testoni, Antonio De Vivo, Giulia Perrone, Sante Tura, Michele Baccarani

Blood (2004) 104 (11): 1489.

https://doi.org/10.1182/blood.V104.11.1489.1489

Published: 2004

Journal Articles

Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells

Elena Tenedini, Maria Elena Fagioli, Nicola Vianelli, Pier Luigi Tazzari, Francesca Ricci, Enrico Tagliafico, Paolo Ricci, Luigi Gugliotta, Giovanni Martinelli, Sante Tura, Michele Baccarani, Sergio Ferrari, Lucia Catani

Blood (2004) 104 (10): 3126–3135.

https://doi.org/10.1182/blood-2003-07-2597

Published: 2004

Includes: Supplemental data

Journal Articles

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation

Blood (2003) 102 (5): 1588–1594.

https://doi.org/10.1182/blood-2002-12-3789

Published: 2003

Journal Articles

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

Michele Cavo, Elena Zamagni, Claudia Cellini, Patrizia Tosi, Delia Cangini, Michela Cini, Lelia Valdrè, Gualtiero Palareti, Luciano Masini, Sante Tura, Michele Baccarani

Blood (2002) 100 (6): 2272.

https://doi.org/10.1182/blood-2002-06-1674

Published: 2002

Journal Articles

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias

Oliver G. Ottmann, Brian J. Druker, Charles L. Sawyers, John M. Goldman, Jose Reiffers, Richard T. Silver, Sante Tura, Thomas Fischer, Michael W. Deininger, Charles A. Schiffer, Michele Baccarani, Alois Gratwohl, Andreas Hochhaus, Dieter Hoelzer, Sofia Fernandes-Reese, Insa Gathmann, Renaud Capdeville, Stephen G. O'Brien

Blood (2002) 100 (6): 1965–1971.

https://doi.org/10.1182/blood-2001-12-0181

Published: 2002

NARROW

Use of Lenalidomide in DEL(5q) MDS. a National AIFA (Agenzia Italiana del Farmaco) Registry Study

Lenalidomide in Myelodysplastic Syndromes with 5q Deletion. Results From the Italian National Cancer Registry

Lenalidomide Is Effective in Heavily Pretreated Non Hodgkin Lymphoma (NHL): Analysis of a Retrospective Data Collection

Deferasirox Chelation Therapy in Transfusion Dependent MDS Patients. Final Report From the Gimema MDS0306 Prospective Trial

Lenalidomide Administration in Heavily Pretreated Patients with Non Hodgkin Lymphoma – First Report of the REVEAL Study (REVlimid® Effectiveness of Administration in patients with Lymphoma)

Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial

Quality of Life in Elderly Patients with Essential Thrombocythemia.

Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.

Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone

Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

Thalidomide-Induced Peropheral Neuropathy in Newly Diagnosed and Pre-Treated Multiple Myeloma Patients.

Imatinib Therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem Cell Transplantation: A Molecular Analysis.

Superiority of Double over Single Autologous Stem Cell Transplantation as First-Line Therapy for Multiple Myeloma.

Superiority of First-Line Thalidomide-Dexamethasone over Vincristine-Doxorubicin-Dexamethasone in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.

Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only